Those without diabetes had increased odds of achieving 50 percent or more excess body-weight loss

Subgroup analysis shows time spent in target glucose range increased in auto mode versus manual mode

Increased risk for death seen for visits on LT4 versus those with isolated elevated TSH who were untreated

Findings seen in women; associations weakened after adjusting for obesity, other metabolic comorbidities

Increase in HbA1c over time linked to decrease in Cognitive Assessment Screening Instrument score

Significant benefit seen for medication adherence, glycemic control with online portal access

Benefit unlikely in half due to limited life expectancy or already being at their HbA1c goal

Early age at peak height velocity also an independent predictor for insulin treatment for T2DM

New regulatory pathway for biologic drugs allows for approval of biosimilars, interchangeable versions

Greater improvements in glycemic control seen for patients using fasting algorithm versus usual care